Abstract:Background Metastasis have considered as an important clinical obstacle in the treatment of human cancer including bladder cancer. Post-transcriptional regulation has emerged as robust effectors of metastasis. MiRNAs are involved in cancer development and progression, acting as tumor suppressors or oncogenes. In this study, we focus on it that microRNA-34a functions as an anti-metastatic microRNA and suppress angiogenesis in bladder cancer by directly targeting CD44. Methods The expression of mir-34a was detected by quantitative real-time PCR. Oligonucleotide and lentivirus were used to overexpress miR-34a. Tube formation assay and transwell assay were used to examine the effect on bladder cancer tube formation, migration and invasion in vitro. Animal models were used to examine the effect on metastasis and angiogenesis in vivo. Luciferase assay was carried out to verify the precise target of miR-34a. Results We not only proved that mir-34a was significantly downregulated in bladder cancer tissues and cell lines but also that circulating miR-34a levels are reduced in bladder cancer, and their levels were positively relevance. Gain-of-function experiments investigated that increased mir-34a expression suppressed tube formation and reduced cell migration and invasion. In vivo metastasis, assays also demonstrated that overexpression of mir34a markedly inhibited bladder cancer metastasis. CD31, an endothelial cell–specific marker which stained in T24 tumors to evaluate for blood vessel density, the immunohistochemistry results showed that blood vessel quantification reduced dramatically in the T24 tumors over-expressing mir-34a. Combining with our previous studies and bioinformatics analysis, we expected that CD44 gene was a direct target of mir-34a, siRNA-mediated knockdown of CD44 partially phenocopied mir-34a overexpression suggesting that the pro-apoptotic role of mir-34a may be mediated primarily through CD44 regulation, whereas restoring the expression of CD44 attenuated the function of mir-34a in bladder cancer cells. Additionally, we identified that EMT (epithelial-mesenchymal transition) related proteins could be regulated by mir-34a which indicated that mir-34a could partially reserve EMT. Conclusion Our study defines a major metastasis and angiogenesis suppressive role for mir-34a, a microRNA functions as a tumor suppressor in bladder cancer by directly targeting CD44, which would be helpful as a therapeutic approach to block bladder cancer metastasis.

Targeted Expression of Mir-34A Using the T-VISA System Suppresses Breast Cancer Cell Growth and Invasion.

Abstract P5-10-10: the Mir-34A is Down-Regulated in Breast Cancer and Breast Stem Cells and a Potential to Eradicating Breast Cancer Via a Systemic Delivery of a VISA –Mir-34A Nanoparticle System

MiR-34a Inhibits Proliferation and Migration of Breast Cancer Through Down-Regulation of Bcl-2 and SIRT1

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

MicroRNA-34a Inhibition of the TLR Signaling Pathway Via CXCL10 Suppresses Breast Cancer Cell Invasion and Migration.

Expression of miR-34a in breast cancer and its molecular mechanism of drug resistance

Mir-34b Inhibits Breast Cancer Cell Epithelial-Mesenchymal Transition (Emt) And Invasion Via Targeting Glioma-Associated Oncogene Protein 1 (Gli1)

MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.

Mir-451A Inhibited Cell Proliferation and Enhanced Tamoxifen Sensitive in Breast Cancer Via Macrophage Migration Inhibitory Factor.

MicroRNA-34a Suppresses Breast Cancer Cell Proliferation and Invasion by Targeting Notch1

MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion

Inhibition of Mirna-34A Promotes Triple Negative Cancer Cell Proliferation by Promoting Glucose Uptake

The inhibition of miRNA-34a on breast cancer cells MCF-7,MDA-MB-231 proliferation and invasion

Nanoparticle Delivery of Mir-34A Eradicates Long-term-cultured Breast Cancer Stem Cells Via Targeting C22ORF28 Directly

Tumor-promoting Properties of Mir-8084 in Breast Cancer Through Enhancing Proliferation, Suppressing Apoptosis and Inducing Epithelial–mesenchymal Transition

MicroRNA-409-5p is Upregulated in Breast Cancer and Its Downregulation Inhibits Cancer Development Through Downstream Target of RSU1

Microrna-34a Suppresses Cell Proliferation by Targeting Lmtk3 in Human Breast Cancer Mcf-7 Cell Line

MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44

Microrna-34a Suppresses the Breast Cancer Stem Cell-Like Characteristics by Downregulating Notch1 Pathway

Restoration of miR-451a-5p/miR-34a-5p could suppress the proliferation and migration of human breast cancer cells through Wnt/β- catenin and ERK/P-ERK signaling pathways

Analysis of miR-34a Expression and Funcition in Breast Cancer Tissues and Cells